CCMW
LABU icon

Cypress Capital Management (Wyoming)’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-22
Closed -$40K – 352
2018
Q3 		$40K Buy
+22
New +$43.2K 0.04% 181
2018
Q2 		– Sell
-5
Closed -$8K – 329
2018
Q1 		$8K Buy
+5
New +$9.31K 0.01% 256

Other funds holding LABU

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s LABU Position: Q4 2018 in Review

Cypress Capital Management (Wyoming) sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2018, closing a stake of 22 shares — an estimated $40K sold.

Cypress Capital Management (Wyoming) first reported a position in LABU in Q1 2018 and held it in 2 quarters. The position peaked at $40K in Q3 2018. 30 funds tracked by Wall St. Rank hold LABU as of Q4 2018.

  • Cypress Capital Management (Wyoming) reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2018 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 22 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2018, an estimated $40K.
  • Cypress Capital Management (Wyoming) first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2018 and held it in 2 quarters.
  • Cypress Capital Management (Wyoming)'s Direxion Daily S&P Biotech Bull 3X ETF position peaked at $40K in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2018.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2018, filed 5 Feb 2019.